Literature DB >> 18055466

Glucose directly links to lipid metabolism through high affinity interaction with peroxisome proliferator-activated receptor alpha.

Heather A Hostetler1, Huan Huang, Ann B Kier, Friedhelm Schroeder.   

Abstract

The pathophysiology of diabetes is characterized not only by elevated glucose but also elevated long chain fatty acid levels. We show for the first time that the peroxisome proliferator-activated receptor-alpha (PPARalpha) binds glucose and glucose metabolites with high affinity, resulting in significantly altered PPARalpha secondary structure. Glucose decreased PPARalpha interaction with fatty acid metabolites and steroid receptor coactivator-1 while increasing PPARalpha interaction with DNA. Concomitantly, glucose increased PPARalpha interaction with steroid receptor coactivator-1, DNA binding, and transactivation of beta-oxidation pathways in the presence of activating ligands. Heterodimerization of PPARalpha to the retinoid X receptor-alpha resulted in even larger increases in transactivation with the addition of glucose. These data suggest that PPARalpha is responsible for maintaining energy homeostasis through a concentration-dependent regulation of both lipids and sugars and that hyperglycemic injury mediated by PPARalpha occurs not only indirectly through elevated long chain fatty acid levels but also through direct action of glucose on PPARalpha.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055466     DOI: 10.1074/jbc.M705138200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  A single amino acid change humanizes long-chain fatty acid binding and activation of mouse peroxisome proliferator-activated receptor α.

Authors:  Dhawal P Oswal; Gerald M Alter; S Dean Rider; Heather A Hostetler
Journal:  J Mol Graph Model       Date:  2014-04-29       Impact factor: 2.518

2.  Glucose regulates fatty acid binding protein interaction with lipids and peroxisome proliferator-activated receptor α.

Authors:  Heather A Hostetler; Madhumitha Balanarasimha; Huan Huang; Matthew S Kelzer; Alagammai Kaliappan; Ann B Kier; Friedhelm Schroeder
Journal:  J Lipid Res       Date:  2010-07-13       Impact factor: 5.922

3.  Novel method to differentiate 3T3 L1 cells in vitro to produce highly sensitive adipocytes for a GLUT4 mediated glucose uptake using fluorescent glucose analog.

Authors:  Divya Vishwanath; Harini Srinivasan; Manjunath S Patil; Sowmya Seetarama; Sachin Kumar Agrawal; M N Dixit; Kakali Dhar
Journal:  J Cell Commun Signal       Date:  2013-01-06       Impact factor: 5.782

4.  Binding site multiplicity with fatty acid ligands: implications for the regulation of PKR kinase autophosphorylation with palmitate.

Authors:  Liang Fang; Hyun Ju Cho; Christina Chan; Michael Feig
Journal:  Proteins       Date:  2014-06-03

5.  Impact of L-FABP and glucose on polyunsaturated fatty acid induction of PPARα-regulated β-oxidative enzymes.

Authors:  Anca D Petrescu; Huan Huang; Gregory G Martin; Avery L McIntosh; Stephen M Storey; Danilo Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-13       Impact factor: 4.052

6.  Divergence between human and murine peroxisome proliferator-activated receptor alpha ligand specificities.

Authors:  Dhawal P Oswal; Madhumitha Balanarasimha; Jeannette K Loyer; Shimpi Bedi; Frances L Soman; S Dean Rider; Heather A Hostetler
Journal:  J Lipid Res       Date:  2013-06-24       Impact factor: 5.922

7.  A novel high-throughput screening assay for putative antidiabetic agents through PPARalpha interactions.

Authors:  Heather A Hostetler; Lindsay R Syler; Lindy N Hall; Guan Zhu; Friedhelm Schroeder; Ann B Kier
Journal:  J Biomol Screen       Date:  2008-09-23

Review 8.  PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.

Authors:  Sean R Pyper; Navin Viswakarma; Songtao Yu; Janardan K Reddy
Journal:  Nucl Recept Signal       Date:  2010-04-16

9.  L-FABP directly interacts with PPARalpha in cultured primary hepatocytes.

Authors:  Heather A Hostetler; Avery L McIntosh; Barbara P Atshaves; Stephen M Storey; H Ross Payne; Ann B Kier; Friedhelm Schroeder
Journal:  J Lipid Res       Date:  2009-03-16       Impact factor: 5.922

10.  Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes.

Authors:  Avery L McIntosh; Barbara P Atshaves; Heather A Hostetler; Huan Huang; Jason Davis; Olga I Lyuksyutova; Danilo Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  Arch Biochem Biophys       Date:  2009-03-12       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.